Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.

Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.
Cervical cancer is one of the widespread cancers in girls accounting for 7.9% of all cancers. In India it’s the second commonest cancer in girls. The immortality of the cancer cell and the comparatively lengthy timeframe from acquisition of an infection to growth of cervical cancer was established.
As main developments like LBC, HPV testing have been launched within the current years, screening has taken a brand new avatar, the Molecular pap!! The goals of this research have been: To evaluate gynecologic cytology and irregular outcomes with respect to standard and LBC. To research the function of HPV cotesting and ancillary checks carried out, that’s, HPV CISH, and p16ink4a by IHC.
About 71 924 Conventional and LBC samples have been included from August 2009 to December 2017. Cases for HPV testing alongside the traditional smears have been 1539. HPV could be examined from the identical LBC vial because the pattern stays steady at room temperature for six weeks. HPV DNA PCR was carried out in our laboratory for High and Low danger genotypes.
Cytology findings have been additionally correlated with histology. Detection charge of SILs in LBC samples have been greater (2.20%). The commonest abnormality was LSIL in LBC and ASCUS in typical smears. LBC with HPV cotesting improves sensitivity and specificity and reduces ambiguous outcomes; permits higher compliance, as a adverse outcome of each checks permits sufferers to get screening each 5 years, thereby rising screening intervals, essential in a useful resource restricted state of affairs.

Touch imprint (TI) cytology of needle core biopsies (NCB) in pathology laboratories: A observe survey of contributors within the College of American Pathologists (CAP) Non Gynecologic Cytopathology (NGC) Education Program.

Intra-procedural evaluation of contact imprint (TI) cytology from needle core biopsies (NCB) is used to make sure pattern adequacy and to offer rapid prognosis in numerous settings. We aimed to survey laboratories for present practices on the use of cytology with NCB. A voluntary supplemental questionnaire together with questions on demographics, personnel concerned, websites, accessioning, and reporting was despatched with the College of American Pathologists (CAP) 2015 Non gynecologic Cytopathology Education Program to survey practices of cytologic evaluation of NCB.
Among 844 respondents, 403 (48%) carried out cytologic evaluation of NCB. Common physique websites included lung (94%; 368/392), liver (87%; 340/ 392), and lymph nodes/spleen (77%; 303/392). Most of the time, a pathologist was current on-site 75% (295/393) for adequacy evaluation which was often verbally reported to the supplier performing the process.
Specimens have been ready by cytotechnologists (50%; 193 of 388) or pathologists (45%; 176 of 388) by touching the core to the slide (50%; 196 of 390) and rolling the core on the slide (45%; 177/390). Among the respondents, 19% stated that cytotechnologists independently carried out rapid evaluation of TI of NCB. Most laboratories (69%; 264/384) evaluated air-dried slides with a modified Giemsa stain and rendered one TI/NCB mixed report (87%, 334/385).
Cervical cancer screening by molecular Pap-transformation of gynecologic cytology.

p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient inhabitants.

Women who check optimistic for a high-risk sort of the human papillomavirus (HPV) require triage testing to determine these girls with cervical intraepithelial neoplasia grade Three or cancer (≥CIN3). Although Pap cytology is taken into account a gorgeous triage check, its applicability is hampered by its subjective nature. This research prospectively in contrast the scientific efficiency of p16/Ki-67 dual-stained cytology to that of Pap cytology, with or with out HPV16/18 genotyping, in high-risk HPV-positive girls visiting gynecologic outpatient clinics (n=446 and age 18-66 years).

From all girls, cervical scrapes (for Pap cytology, HPV16/18 genotyping, and p16/Ki-67 dual-stained cytology) and colposcopy-directed biopsies have been obtained. This is the primary survey carried out particularly to find out the observe of adequacy evaluation of TI of NCB. Cytotechnologists are usually not performing adequacy evaluation of TI with out pathologist oversight. A single report is often issued which incorporates the adequacy evaluation as a component of the ultimate report.

The sensitivity of p16/Ki-67 dual-stained cytology for ≥CIN3 (93.8%) did neither differ considerably from that of Pap cytology (87.7%; ratio 1.07 and 95% confidence interval (CI): 0.97-1.18) nor from that of Pap cytology mixed with HPV16/18 genotyping (95.1%; ratio 0.99 and 95% CI: 0.91-1.07). However, the specificity of p16/Ki-67 dual-stained cytology for ≥CIN3 (51.2%) was considerably greater than that of Pap cytology (44.9%; ratio 1.14 and 95% CI: 1.01-1.29) and Pap cytology mixed with HPV16/18 genotyping (25.8%; ratio 1.99 and 95% CI: 1.68-2.35).

After exclusion of girls who had been referred as a result of of irregular Pap cytology, the specificity of p16/Ki-67 dual-stained cytology for ≥CIN3 (56.7%) remained the identical, whereas that of Pap cytology (60.3%) elevated considerably, leading to the same specificity of each assays (ratio 0.94 and 95% CI: 0.83-1.07) on this sub-cohort. In abstract, p16/Ki-67 dual-stained cytology has a superb scientific efficiency and is an fascinating goal microscopy-based triage device for high-risk HPV-positive girls.

Grace's Media

CM021-350 50x500ml
EUR 585

Grace's Media

CMP21-001 10x1L
EUR 159

Grace's Media

CMP21-010 10L
EUR 146

Grace's Media

CMP21-050 50L
EUR 336

Endothelial Cryopreserve Media

FM300 10 ml
EUR 257

Human Chondrocytes Media

PC00B3 500 ml
EUR 362

Pericyte-Growth Media

PGB001 500 ml
EUR 297

Pericyte Basal Media

PGB002 475 ml
EUR 271

Astrocyte-Growth Media

PGB003 500 ml
EUR 297

Astrocyte Basal Media

PGB004 500 ml
EUR 271

ENDO-Growth Media

MED001 500 ml
EUR 362

ENDO Basal Media

MED002 500 ml
EUR 207

Ceraplex Media 199

CCM37-050 500ml Ask for price

NSC maintenance Media

ASE-9234SM 100 ml
EUR 131
Description: 18 month

Neuron Induction Media

ASE-9321NI 100 ml
EUR 131
Description: 18 month

Neuron Maturation Media

ASE-9321NM 100 ml
EUR 131
Description: 18 month

Astro Induction Media

ASE-9322AI 100 ml
EUR 131
Description: 18 month

Astro Maturation Media

ASE-9322AM 100 ml
EUR 131
Description: 18 month

DOPA Induction Media

ASE-9323DI 100 ml
EUR 147.2
Description: 18 month

DOPA Maturation Media

ASE-9323DM 100 ml
EUR 155.3
Description: 18 month

FluorLast? Mounting Media

1213-20
EUR 142

YP BASE MEDIA

Y25-110-10kg 10 kg
EUR 899

YP BASE MEDIA

Y25-110-2kg 2kg
EUR 235

YP BASE MEDIA

Y25-110-500g 500 g
EUR 100

Media 199 All-in-One Complete Media(10X), Singel quote

CAM37-005 50ml
EUR 246

MC-Easy Media Bonus Pack (includes Growth and Induction Media)

MN950A-1 5 preps
EUR 275

ENDO-Growth Media Kit

EGK001 500 ml
EUR 362

Human BBB Model Media

NMBBB01 500 ml - Media
EUR 435

Cell Freezing Media I

CA301-005 50ml
EUR 205

Cell Freezing Media II

CA302-005 50ml
EUR 228

Cell Freezing Media III

CA303-005 50ml
EUR 242

Leibovitz'a L-15 Media

CM030-050 500ml
EUR 84

Leibovitz'a L-15 Media

CM030-300 6x500ml
EUR 169

Leibovitz'a L-15 Media

CM030-310 10x500ml
EUR 203

Leibovitz'a L-15 Media

CM030-320 20x500ml
EUR 383

Leibovitz'a L-15 Media

CM030-350 50x500ml
EUR 690

Leibovitz'a L-15 Media

CM031-050 500ml
EUR 84

Leibovitz'a L-15 Media

CM031-300 6x500ml
EUR 169

Leibovitz'a L-15 Media

CM031-310 10x500ml
EUR 203

Leibovitz'a L-15 Media

CM031-320 20x500ml
EUR 383

Leibovitz'a L-15 Media

CM031-350 50x500ml
EUR 690

McCoy's 5A Media (Modified)

CM032-050 500ml
EUR 88

McCoy's 5A Media (Modified)

CM032-300 6x500ml
EUR 165

McCoy's 5A Media (Modified)

CM032-310 10x500ml
EUR 219

McCoy's 5A Media (Modified)

CM032-320 20x500ml
EUR 340

McCoy's 5A Media (Modified)

CM032-350 50x500ml
EUR 585

McCoy's 5A Media (Modified)

CM033-050 500ml
EUR 85

McCoy's 5A Media (Modified)

CM033-300 6x500ml
EUR 165

McCoy's 5A Media (Modified)

CM033-310 10x500ml
EUR 219

McCoy's 5A Media (Modified)

CM033-320 20x500ml
EUR 340

McCoy's 5A Media (Modified)

CM033-350 50x500ml
EUR 585

Permanent Mounting Media (Aqueous)

PMT030 30 ml
EUR 109

Permanent Mounting Media (Aqueous)

PMT999 1000 ml
EUR 759

Buffered Glycerol Mounting Media

GMM003 3 ml
EUR 61

Buffered Glycerol Mounting Media

GMM030 30 ml
EUR 72

Buffered Glycerol Mounting Media

GMM500 500 ml
EUR 183

Buffered Glycerol Mounting Media

GMM999 1000 ml
EUR 260

Media Optimization Kit™

100 kit
EUR 122

Dream Media Optimization Kit

184 Kit
EUR 162

Michel's Transport Fluid

MTF-10000 10 L
EUR 762

Michel's Transport Fluid

MTF-20000 20 L
EUR 1340

Michel's Transport Fluid

MTF500 500 ml
EUR 98

Michel's Transport Fluid

MTF999 1000 ml
EUR 127

Human L-EGF (Media Grade)

NM001 1 mg
EUR 438

Human L-EGF (Media Grade)

NM005 5 mg
EUR 717

Human IGF-II (Media Grade)

OM001 1 mg
EUR 902

Human IGF-II (Media Grade)

OU100 100 µg
EUR 327

Human IGF-I (Media Grade)

IM001 1 mg
EUR 624

Human IGF-I (Media Grade)

IM005 5 mg
EUR 161

Human IGF-I (Media Grade)

IU100 100 µg
EUR 327

Pancreatic Stellate CAF Maintaining Media

PC00B5 500 ml
EUR 321

Mouse ES Cell Culture Media

M16101 500 mL
EUR 1114

Rat Neurosphere-Progenitors Proliferation Media

M36111 500 ml
EUR 826

CMRL 1066, CIT CULTURE MEDIA

98-304-CV 500 mL/pk
EUR 65
Description: Specialty Media; Islet products

Exosome-depleted FBS Media Supplement

EXO-FBS-250A-1 250 ml
EUR 881

Exosome-depleted FBS Media Supplement

EXO-FBS-50A-1 50 ml
EUR 241

ExoPure? Isolation Kit   (Cell Media)

K1237-10
EUR 664

ExoPure? Isolation Kit   (Cell Media)

K1237-2
EUR 392

APF Media Optimization Kit™

0100-APF kit
EUR 122

Media Optimization Kit™, Liquid

128 kit
EUR 140

Michel's Transport Wash Buffer

MTW-10000 10 L
EUR 706

Michel's Transport Wash Buffer

MTW-20000 20 L
EUR 1297

Michel's Transport Wash Buffer

MTW500 500 ml
EUR 98

Michel's Transport Wash Buffer

MTW999 1000 ml
EUR 127

Human [Arg3] IGF-I (Media Grade)

LM001 1 mg
EUR 624

Human [Arg3] IGF-I (Media Grade)

LM005 5 mg
EUR 161

Human [Arg3] IGF-I (Media Grade)

LU100 100 µg
EUR 299

Ceracryo Xeno-Free Cell Freezing Media

C0667-005 50ml
EUR 219

Ceracryo Xeno-Free Cell Freezing Media

C0667-010 100ml
EUR 273

Grace's Supplemented Media (Hink's TNM-FH)

CM023-050 500ml
EUR 89

Grace's Supplemented Media (Hink's TNM-FH)

CM023-300 6x500ml
EUR 196

Grace's Supplemented Media (Hink's TNM-FH)

CM023-310 10x500ml
EUR 267

Grace's Supplemented Media (Hink's TNM-FH)

CM023-320 20x500ml
EUR 383

Grace's Supplemented Media (Hink's TNM-FH)

CM023-350 50x500ml
EUR 620

Every gynecologic cytology specimen examined by each a CT and a CP from December 2004 to March 2015 was extracted from the laboratory info system; glandular interpretations have been excluded. Excel and SAS have been used for CT-CP pair evaluation. CT-CP pairs with fewer than 32 specimens (the bottom quartile) have been excluded. For the remaining CT-CP pairs, 30 specimens or 10% of the specimens (whichever was greater) have been randomly chosen for comparability by a weighted κ statistic. κ values larger than 0.6 represented good settlement inside CT-CP pairs.

Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.

Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.
To consider the prognostic influence of peritoneal washing cytology in sufferers with endometrial and ovarian cancers. We retrospectively recognized 86 people with ovarian carcinomas, ovarian borderline tumors and endometrial adenocarcinomas. The sufferers had been handled at Shahid Sadoughi Hospital and Ramazanzadeh Radiotherapy Center, Yazd, Iran between 2004 and 2012. Survival variations have been decided by Kaplan-Meier evaluation. Multivariate evaluation was carried out utilizing the Cox regression methodology. A p<0.05 value was thought of statistically vital.
There have been 36 sufferers with ovarian carcinomas, Four with borderline ovarian tumors and 46 with endometrial carcinomas. The imply age of the sufferers was 53.8±15.2 years. In sufferers with ovarian carcinoma the general survival in the adverse cytology group was higher than the sufferers with optimistic cytology though this distinction failed to achieve statistical significance (p=0.30). At Zero to 50 months the general survival was higher in sufferers with endometrial adenocarcinoma and adverse cytology than the sufferers with optimistic cytology however then it decreased (p=0.85).
At 15 to 60 months sufferers with FIGO 2009 stage IA-II endometrial andocarcinoma and adverse peritoneal cytology had a superior survival price in comparison with 1988 IIIA and optimistic cytology solely, though this distinction failed to achieve statistical significance(p=0.94). Multivariate evaluation utilizing Cox proportional hazards mannequin confirmed that stage and peritoneal cytology have been predictors of loss of life.

Diagnostic value of HMGB1 immunostaining on cell blocks from residual liquid-based gynecologic cytology specimens.

Aberrant expression of excessive mobility group field 1 (HMGB1) is related to tumor improvement and development. The present examine was carried out to guage the importance of HMGB1 immunostaining on cell block (CB) preparations in the analysis of neoplastic and preneoplastic lesions of the cervix. The CBs have been ready from 157 residual liquid-based gynecologic cytology specimens which have been collected from ladies whose cervical lesions had been confirmed by histopathology.

The expression of HMGB1 and p16INK4A (p16) was visualized by immunocytochemistry on the CB preparations, and the affiliation of their expression patterns was correlated with the severity of cervical lesions. HeLa cells have been used as optimistic management. HMGB1 expression was noticed in dysplastic and neoplastic cells and elevated together with the development of cervical neoplasia.

The charges of optimistic staining for HMGB1 in cervical intraepithelial neoplasia 1 (CIN-1), CIN-2, CIN-3, and invasive squamous cell carcinomas (ISCCs) have been 69.4, 96.9, 100.0, and 100.0%, respectively. The variations between optimistic charges of sufferers with persistent cervicitis and numerous CINs in addition to ISCCs have been vital (P < 0.005).

The variations in optimistic staining charges between every two CIN teams, and variations between CIN-1\/2 and ISCCs, have been additionally vital (P < 0.005). The expression sample of HMGB1 was typically correlated with that of p16 (P < 0.001). HMGB1 staining was noticed in some p16-negative specimens. HMGB1 immunostaining on a CB from gynecologic cytology specimens is doubtlessly useful for the screening of cervical lesions in instances with questionable cytology.

We in contrast cytotechnologists’ efficiency and reproducibility of guide and automatic screening of 10,165 consecutive cervical cytology slides examined at Barretos Cancer Hospital utilizing the FocalPoint system. In whole, 83% of atypical squamous cells of undetermined significance and higher have been categorized as quintiles 1 and a couple of; no high-grade squamous intraepithelial lesions and higher have been noticed in quintile 5.
No statistically vital variations have been discovered between guide and automatic screening, utilizing cervical biopsy specimens because the gold customary. Our outcomes present good correlation of peritoneal cytology with prognosis in sufferers with ovarian carcinoma. In endometrial carcinoma it had prognostic significance. Additional analysis is warranted.
Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.

Optimal z-axis scanning parameters for gynecologic cytology specimens.

The use of digital microscopy (VM) in scientific cytology has been restricted as a result of incapacity to focus via three dimensional (3D) cell clusters with a single focal aircraft (2D photos). Limited data exists concerning the optimum scanning parameters for 3D scanning. The function of this examine was to find out the optimum quantity of the focal aircraft ranges and the optimum scanning interval to digitize gynecological (GYN) specimens ready on SurePath™ glass slides whereas sustaining a manageable file measurement.
The iScanCoreo Au scanner (Ventana, AZ, USA) was used to digitize 192 SurePath™ glass slides at three focal aircraft ranges at 1 μ interval. The digitized digital photos (VI) have been annotated utilizing BioImagene’s Image Viewer. Five individuals interpreted the VI and recorded the focal aircraft stage at which they felt assured and later interpreted the corresponding glass slide specimens utilizing mild microscopy (LM). The individuals accomplished a survey about their experiences. Inter-rater settlement and concordance between the VI and the glass slide specimens have been evaluated.

Plant Genomic DNA Kit

20-abx098077
  • EUR 411.00
  • EUR 230.00
  • 200 rxns
  • 50 rxns

Bacteria Genomic DNA Kit

20-abx098080
  • EUR 105.00
  • EUR 244.00
  • 2 rxns
  • 50 rxns

Micro Genomic DNA Kit

20-abx098242
  • EUR 105.00
  • EUR 328.00
  • 2 rxns
  • 50 rxns

Blood Genomic DNA Kit

abx098868-50rxns 50 rxns
EUR 272

Plant Genomic DNA Kit

abx294004-50preps 50 preps
EUR 398

Animal Genomic DNA Kit

abx294005-100preps 100 preps
EUR 523

Animal Genomic DNA Kit

abx294005-50preps 50 preps
EUR 398

Genomic DNA Isolation Kit

K2118-50 50 assays
EUR 321

Soil Genomic DNA Kit

K1411-250
EUR 561

Soil Genomic DNA Kit

K1411-50
EUR 316

Insect Genomic DNA Kit

K1412-250
EUR 561

Insect Genomic DNA Kit

K1412-50
EUR 316

Mollusc Genomic DNA Kit

K1413-250
EUR 561

Mollusc Genomic DNA Kit

K1413-50
EUR 316

Yeast Genomic DNA Kit

K1414-250
EUR 561

Yeast Genomic DNA Kit

K1414-50
EUR 316

Fungal Genomic DNA Kit

K1415-250
EUR 561

Fungal Genomic DNA Kit

K1415-50
EUR 316

Genomic DNA Isolation Kit

K281-50
EUR 272

Fully CpG Methylated Human Genomic DNA

X10000 10 µg/100 µl Ask for price
Description: The best epigenetics products

Genomic DNA Extraction and Purification

EP10012 100 Tests
EUR 505

Genomic DNA Extraction KitAnimal Tissue

FYG102-100P 100 Preps Ask for price

Genomic DNA Extraction KitAnimal Tissue

FYG102-300P 300 Preps Ask for price

Genomic DNA Extraction KitAnimal Tissue

FYG102-50P 50 Preps Ask for price

Genomic DNA Extraction Maxi KitPlant

FYG104-10P 10 Preps Ask for price

Genomic DNA Extraction Maxi KitPlant

FYG104-25P 25 Preps Ask for price

ISOLATE II Genomic DNA Kit

BIO-52065 10 preps Ask for price

ISOLATE II Genomic DNA Kit

BIO-52066 50 preps Ask for price

ISOLATE II Genomic DNA Kit

BIO-52067 250 preps Ask for price

Plant Genomic DNA extraction buffer

20-abx098075
  • EUR 286.00
  • EUR 105.00
  • 100 ml
  • 1.2 ml

Marine Animal Genomic DNA Kit

20-abx098079
  • EUR 105.00
  • EUR 244.00
  • 2 rxns
  • 50 rxns

FFPE Tissue Genomic DNA Kit

abx098866-50rxns 50 rxns
EUR 272

Zenoquick Genomic DNA Purification Kit

Z2003-200 200 preps
EUR 631

Zenoprep Genomic DNA Purification Kit

Z2004-400 400 preps
EUR 550

AccuRT Genomic DNA Removal Kit

G488 200 Reactions
EUR 82

Bacterial Genomic DNA Isolation Kit

K309-100
EUR 376

100 BP DNA LADDER, 500UL PER KIT

M-DNA-100BP 1/pk
EUR 73
Description: Bioscience Mol Bio; DNA Ladder

1 KB DNA LADDER, 500UL PER KIT

M-DNA-1KB 1/pk
EUR 70
Description: Bioscience Mol Bio; DNA Ladder

Rapid Fungal Genomic DNA Isolation Kit

FT71415 50Preps
EUR 76.64

Genomic DNA Extraction Mini KitPlant Tissue

FYG103-100P 100 Preps Ask for price

Easy3-Plant Genomic DNA Isolation Kit

FYG503-100P 100 Preps Ask for price

Easy3-Plant Genomic DNA Isolation Kit

FYG503-500P 500 Preps Ask for price

Rapid Bacteria Genomic DNA Isolation Kit

BS8225 50Preps
EUR 76.64

Rapid Yeast Genomic DNA Extraction Kit

BS8227 50Preps
EUR 76.64

Rapid Blood Genomic DNA Extraction Kit

BT4782 50Preps
EUR 76.64

Rapid Animal Genomic DNA Extraction Kit

AT4780 10Preps
EUR 69.03

Rapid Animal Genomic DNA Extraction Kit

AT4781 50Preps
EUR 126.13

Rapid Animal Genomic DNA Extraction Kit

AT4782 250preps
EUR 354.5

Genomic DNA Kit (No RNase A)

20-abx098862
  • EUR 398.00
  • EUR 230.00
  • 200 rxns
  • 50 rxns

Plant Tissue Genomic DNA Isolation Kit

K316-100
EUR 376

Mammalian Cell Genomic DNA Isolation Kit

K967-100
EUR 381

VAHTS Human Genomic DNA Quantification and QC Kit

NQ201 300 rxn
EUR 575

One-tube Plant Genomic DNA Extraction Kit

PT71816 100preps
EUR 88.06

One-tube Plant Genomic DNA Extraction Kit

PT71817 500Preps, 500prep
EUR 202.25

Blood Genomic DNA Extraction Mini Kit (100prep)

FABGK-100 100 preps
EUR 165

Blood Genomic DNA Extraction Mini Kit (300prep)

FABGK-300 300 preps
EUR 266

FavorPrep Genomic DNA Clean-Up Kit (50prep)

FAGDC-001 50 preps
EUR 129

FavorPrep Genomic DNA Clean-Up Kit (200prep)

FAGDC-001-1 200 preps
EUR 204

Plant Genomic DNA Extraction Mini Kit (50prep)

FAPGK-001 50 preps
EUR 158

Plant Genomic DNA Extraction Mini Kit (100prep)

FAPGK-001-1 100 preps
EUR 204

Plant Genomic DNA Extraction Mini Kit (200prep)

FAPGK-001-2 200 preps
EUR 274

Plant Genomic DNA Extraction Maxi Kit (10prep)

FAPGK-002 10 preps
EUR 201

Plant Genomic DNA Extraction Maxi Kit (24prep)

FAPGK-002-1 24 preps
EUR 317

Genomic DNA Extraction Mini KitBlood/Cultured Cells

FYG100-300P 300 Preps Ask for price

Genomic DNA Extraction Mini KitBlood/Cultured Cells

FYG101-100P 100 Preps Ask for price

gRazor, Genomic DNA Removal Enzyme Mix(5X)

R5800-100 100ul
EUR 300

gRazor, Genomic DNA Removal Enzyme Mix(5X)

R5800-500 500ul
EUR 1144

Mouse Tail Genomic DNA Extraction Kit(250)

M9100-250 250 prep
EUR 536

5-min. Genomic DNA Prep for PCR

P930-100 - Ask for price

5-min. Genomic DNA Prep for PCR

P930-5 - Ask for price

5-min. Genomic DNA Prep for PCR

P930-500 - Ask for price

One-Tube Bacteria Genomic DNA Isolation Kit

BS8413 100preps
EUR 78.93

One-Tube Bacteria Genomic DNA Isolation Kit

BS8414 500Preps, 500prep
EUR 165.71

One-4-All Genomic DNA Miniprep Kit

BS88503 50Preps
EUR 116.99

One-4-All Genomic DNA Miniprep Kit

BS88504 100preps
EUR 170.58

One-4-All Genomic DNA Miniprep Kit

BS88505 250preps
EUR 327.96

Blood Genomic DNA Kit (0.1-20 ml)

abx098074-For200mlBlood For 200 ml Blood
EUR 356

Blood Genomic DNA Kit (0.1-20 ml)

abx098074-For50mlBlood For 50 ml Blood
EUR 217

Blood Genomic DNA Kit (5-250 ul)

20-abx098078
  • EUR 411.00
  • EUR 230.00
  • 200 rxns
  • 50 rxns

Bacteria Genomic DNA Kit (No RNase A)

abx098240-50rxns 50 rxns
EUR 230

Food and Fodder Security Genomic DNA Kit

abx098241-50rxns 50 rxns
EUR 314

Plant Genomic DNA Kit(No RNase A)

20-abx098863
  • EUR 384.00
  • EUR 230.00
  • 200 rxns
  • 50 rxns

Blood Genomic DNA Kit (No RNase A)

20-abx098864
  • EUR 384.00
  • EUR 230.00
  • 200 rxns
  • 50 rxns

Blood Genomic DNA Kit (with Magnetic Stand)

abx098867-50rxns 50 rxns
EUR 300

T-Pro Genomic DNA Midi Kit (20)

RB94-NGM020 20preps/kit
EUR 222

T-Pro Genomic DNA Mini Kit (100)

RB94-NGS100 100preps/kit
EUR 213

Blood genomic DNA extraction and purification kit

K1443-100
EUR 479

96-Well Plate Bacteria Genomic DNA Miniprep Kit

SK1292 2XPlates, 192prep
EUR 175.71

96-Well Plate Bacteria Genomic DNA Miniprep Kit

SK1295 5XPlates, 480prep
EUR 324.92

96-well Genomic DNA Extraction Kit (1 plates)

FADWE-96001 1 prep
EUR 158

96-well Genomic DNA Extraction Kit (2 plates)

FADWE-96002 2 preps
EUR 213

96-well Genomic DNA Extraction Kit (4 plates)

FADWE-96004 4 preps
EUR 317

Fungi/ Yeast Genomic DNA Extraction Mini Kit(50prep)

FAFYG001 50 preps
EUR 274

Fungi/ Yeast Genomic DNA Extraction Mini Kit(100prep)

FAFYG001-1 100 preps
EUR 390

96-Well Plate Animal Genomic DNA Miniprep Kit

BS437 5XPlates, 480prep
EUR 362.98

96-Well Plate Animal Genomic DNA Miniprep Kit

BS4372 2XPlates, 192prep
EUR 195.5
This examine decided an total excessive intra-rater diagnostic concordance between glass and VI (89-97%), nonetheless, the inter-rater settlement for all instances was larger for LM (94%) in contrast with VM (82%). Survey outcomes point out individuals discovered low grade dysplasia and koilocytes straightforward to diagnose utilizing three focal aircraft ranges
the picture enhancement software was helpful and focusing via the cells helped with interpretation; nonetheless, the individuals discovered VI with hyperchromatic crowded teams difficult to interpret. Participants reported they like utilizing LM over VM. This examine helps utilizing three focal aircraft ranges and 1 μ interval to develop the use of VM in GYN cytology. Future enhancements in expertise and acceptable coaching ought to make this format a extra preferable and sensible possibility in scientific cytology.

Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences.

Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences.

Liquid-based preparations (LBPs) have largely changed conventional Papanicolaou smears (CPS) for cervical samples within the United States and in lots of different industrialized international locations. The two FDA-approved LBP at present in use embody ThinPrep (TP), (Hologic Inc., Bedford, MA) and SurePath (SP), (BD Diagnostic, Burlington, NC). Split-sample and direct-to-vial research have proven that LBPs present an general enchancment in pattern assortment and processing

scale back artifacts that intrude in prognosis, are extra delicate, might be utilized for ancillary checks and are a cost-effective alternative for CPS. Comparative analyses of diagnostic accuracy point out that LBPs carry out a minimum of in addition to CPS. However, the added benefits of standardized, automated preparations and screening, lowered unsatisfactory fee, improved specimen adequacy and means to carry out human papillomavirus (HPV) check, are sufficient to proceed use of LBP. The cytologic options in LBP are just like CPS with refined variations, notably in background info.

There are additionally refined variations between the 2 LBPs, SP and TP, that are reflective of completely different sampling gadgets, assortment media, and processing methods. Architecturally, LBP exhibits smaller cell clusters and sheets and extra dyscohesion. Cytologically, enhanced nuclear options and smaller cell measurement are extra distinguished.

Advances in liquid-based Papanicolaou’s (Pap) check have result in well-defined affected person administration tips by the American Society for Colposcopy and Cervical Pathology. Herein, we review these features of Pap check together with, morphology, automation, ancillary checks (HPV and immunochemistry), pertinent QA/QC screens, affected person administration tips, and review of pertinent literature.

After an intense interval of laboratory coaching, a cohort of 10,233 present and seeded irregular slides have been labeled initially by FPGS. Manual screening and reclassification blinded to the FPGS outcomes have been then carried out. Any adequacy and/or cytodiagnostic discrepancy between the two screening strategies subsequently was resolved by way of a consensus course of (fact).

The efficiency of every technique’s adequacy and cytodiagnosis vis-a-vis the reality was established. The sensitivity and specificity of every technique at Four cytodiagnostic thresholds (atypical squamous cells of undetermined significance or worse [ASC-US+], low-grade squamous intraepithelial lesion or worse [LSIL+], high-grade squamous intraepithelial lesion or worse [HSIL+], and carcinoma) have been in contrast. The false-negative fee for every cytodiagnosis was decided.

Assessment of handbook workload limits in gynecologic cytology: reconciling knowledge from Three main potential trials of automated screening gadgets.

Previous potential research have proven completely different outcomes when evaluating automated and handbook screening of gynecologic cytology. The outcomes of Three massive potential research have been reviewed and relative sensitivity used as a gold normal. No vital variations could possibly be proven in relative sensitivity between the ThinPrep Imaging System and the FocalPoint GS Imaging System (P>> .05). When handbook screening was restricted to lower than 6 hours per day

50 or fewer slides per day, and a minimum of 6 minutes per slide (<10 slides/h), the relative sensitivity for automation was considerably decrease for atypical squamous cells of undetermined significance and above (ASC+) (0.81; 95% confidence interval [CI], 0.79-0.83) than when handbook screening was not restricted (1.07; 95% CI, 1.03-1.10).

All Three websites that screened 10 or extra slides per hour manually had a relative sensitivity for automation that was considerably increased for high-grade squamous intraepithelial lesions and above (HSIL+) than for the remaining teams who screened lower than 10 slides per hour (1.40 [95% CI, 1.22-1.60] vs 0.97 [95% CI, 0.95-1.00]). These outcomes recommend that location discovering of abnormalities (ASC+) could also be extra strongly related to time spent screening per day,

whereas classification/interpretation expertise (HSIL+) could rely on time spent on a person case. There is not any proof that automated screening gadgets are extra delicate than handbook screening carried out at decrease well-defined workloads. More restricted workloads (≤41 slides/d, ≤4.5 h/d) for handbook screening could carry out considerably higher than automated screening gadgets as measured by histologic cervical intraepithelial neoplasia 2 and above.

Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences.

The function of monitoring interpretive charges, concordance between cytotechnologist and pathologist interpretations earlier than sign-out, and turnaround time in gynecologic cytology high quality assurance: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 1.

The College of American Pathologists (CAP) performed a nationwide survey of gynecologic cytology high quality assurance (QA) practices. Experts in gynecologic cytology have been requested to affix 5 working teams that studied the survey knowledge on completely different features of QA. Evaluating the survey knowledge and follow-up questions on-line, along with a review of pertinent literature, the working teams developed a collection of preliminary statements on good laboratory practices in cytology QA. These have been offered at a consensus convention and digital voting occurred.
To consider a set of QA screens in gynecologic cytology. Working group 1 evaluated (1) monitoring interpretive fee classes for Papanicolaou checks (Pap checks), (2) concordance of cytotechnologist and pathologist interpretations earlier than sign-out, and (3) turnaround time for Pap checks. The statements are primarily based on a survey of gynecologic cytology QA observe patterns and of opinions from working group members and consensus convention attendees.

Novo? cDNA Kit

M1165-100
EUR 354

Novo? cDNA Kit

M1165-25
EUR 267

Evo? cDNA Supermix

M1168-100
EUR 381

Evo? cDNA Supermix

M1168-25
EUR 267

Novo? cDNA Supermix

M1169-100
EUR 441

Novo? cDNA Supermix

M1169-25
EUR 289

Mouse Lung PrimaCell2: Normal Lung Fibroblasts

2-82065 1 Kit Ask for price

Rat Lung PrimaCell1: Normal Lung Fibroblasts

2-82564 1 Kit Ask for price

Human Lung PrimaCell1: Normal Lung Fibroblasts

2-96081 1 Kit Ask for price

First-Strand cDNA Synthesis SuperMix (cDNA up to 12 kb)

20-abx09801620ulSystems
  • EUR 620.00
  • EUR 523.00
  • 100 rxns × 20 ul Systems
  • 50 rxns × 20 ul Systems

First-Strand cDNA Synthesis SuperMix (cDNA up to 15 kb)

20-abx09802120ulSystems
  • EUR 871.00
  • EUR 662.00
  • 100 rxns × 20 ul Systems
  • 50 rxns × 20 ul Systems

cDNA Probe Diluent Solution

AR0063 5mL
EUR 106

Tetro cDNA Synthesis Kit

BIO-65042 30 Reactions Ask for price

Tetro cDNA Synthesis Kit

BIO-65043 100 Reactions Ask for price

SensiFAST cDNA Synthesis Kit

BIO-65053 50 Reactions Ask for price

SensiFAST cDNA Synthesis Kit

BIO-65053/S Sample Ask for price

SensiFAST cDNA Synthesis Kit

BIO-65054 250 Reactions Ask for price

Human eNOS cDNA probe

eNOS51-D-2 2 ug
EUR 445

Plant Tissue cDNA: Arabidopsis

PC34-310 10 rxn
EUR 415

OneScriptPlus cDNA Synthesis Kit

G235 25 x 20 ul reactions
EUR 97

OneScriptPlus cDNA Synthesis Kit

G236 100 x 20 ul reactions
EUR 169

OneScriptPlus cDNA Synthesis SuperMix

G453 25 x 20 ul reactions
EUR 97

OneScriptPlus cDNA Synthesis SuperMix

G454 100 x 20 ul reactions
EUR 169

circRNA cDNA Synthesis Kit

G627 25 rxn (20 ul/rxn)
EUR 309

Evo™ cDNA Kit

M1164-100 Ask for price

Evo™ cDNA Kit

M1164-25 Ask for price

Novo? Transcriptome cDNA Kit

M1167-100
EUR 952

Novo? Transcriptome cDNA Kit

M1167-25
EUR 441

Hamster Mono Anti-Mouse CD3e IgG (Hamster IgG)

MCD003E-M 100 Tests
EUR 482

Hamster Mono Anti-Mouse CD3z IgG (Hamster IgG)

MCD003Z-M 100 ug
EUR 482

Hamster CD28 Antibody

abx139999-01mg 0.1 mg
EUR 286

Hamster CD3 Antibody

abx140000-01mg 0.1 mg
EUR 286

Hamster CD3 Antibody

abx140001-01mg 0.1 mg
EUR 286

Hamster CD80 Antibody

abx140014-01mg 0.1 mg
EUR 286

Hamster CD154 Antibody

abx140091-01mg 0.1 mg
EUR 342

Hamster CD154 Antibody

abx140092-01mg 0.1 mg
EUR 286

Hamster Helios Antibody

abx140094-01mg 0.1 mg
EUR 411

Recombinant Hamster Uter

P0138 100ug
EUR 522.36
Description: Recombinant Hamster protein for Uter

Hamster Transthyretin (TTR)

QY-E90097 96T
EUR 478

Rat Lung PrimaCell1: Normal Lung Fibroblasts Growth Medium

9-25064 5 x 100 ml Ask for price

Mouse Lung PrimaCell2: Normal Lung Fibroblasts Growth Medium

9-32065 5 x 100 ml Ask for price

Human Lung PrimaCell1: Normal Lung Fibroblasts Growth Medium

9-46081 5 x 100 ml Ask for price

Human Lung TRYPTASE

DAG105 10g
EUR 914

Lung Cancer Exosome

P141-LG - Ask for price

cDNA Synthesis SuperMix for qPCR

20-abx09801920ulSystems
  • EUR 690.00
  • EUR 565.00
  • 100 rxns ×20 ul Systems
  • 50 rxns × 20 ul Systems

amfiRivert cDNA Synthesis Master Mix

R5101-050 50 rxns
EUR 415

amfiRivert cDNA Synthesis Master Mix

R5101-100 2X50 rxns
EUR 847

amfiRivert cDNA Synthesis Master Mix

R5101-200 4X50 rxns
EUR 1211

amfiRivet cDNA Synthesis 2X Buffer

R5102-050 500ul
EUR 134

amfiRivet cDNA Synthesis 2X Buffer

R5102-100 2x500ul
EUR 192

Mouse iNOS (macrophage) cDNA probe

iNOS61-D-2 2 ug
EUR 445

Monkey (Rhesus) cDNA Tissue: Thyroid

MR34-265 10 rxn
EUR 415

Human Adult cDNA Tissue: Skin

HA-218 10 rxn
EUR 415

Human Adult cDNA Tissue: Testis

HA-260 10 rxn
EUR 415

Human Tumor Tissue: Breast cDNA

HT05-090 10 rxn
EUR 415

Total-Transcriptome cDNA Synthesis Kit

G904 25 reactions
EUR 224

Total-Transcriptome cDNA Synthesis Kit

G905 100 reactions
EUR 544

Evo? cDNA Kit (gDNA Removal)

M1166-100
EUR 381

Hamster Mono Anti-Mouse CD25 , Pur. Low Endotoxin (Hamster IgG)

MCD027-M 100 ug
EUR 482

Human Lung Tissue Preparation Buffer 1: Normal Lung Fibroblasts

9-80081 1 x 100 ml Ask for price

Mouse Lung Tissue Preparation Buffer 2: Normal Lung Fibroblasts

9-80179 1 x 100 ml Ask for price

Rat Lung Tissue Preparation Buffer 1: Normal Lung Fibroblasts

9-80271 1 x 100 ml Ask for price

Hamster Anti CD28 Antibody

20-abx137056
  • EUR 356.00
  • EUR 523.00
  • 0.5 mg
  • 1 mg

Hamster CD3 Antibody (PerCP)

abx140002-01mg 0.1 mg
EUR 398

Hamster CD3 Antibody (PE)

abx140003-01mg 0.1 mg
EUR 328

Hamster CD3 Antibody (APC)

abx140004-01mg 0.1 mg
EUR 370

Hamster CD3 Antibody (Biotin)

abx140005-01mg 0.1 mg
EUR 272

Hamster CD3 Antibody (FITC)

abx140006-01mg 0.1 mg
EUR 314

Hamster CD154 Antibody (FITC)

abx140093-01mg 0.1 mg
EUR 537

Hamster Helios Antibody (PE)

abx140095-100tests 100 tests
EUR 537

Antibody for Hamster HSP110

SPC-195C 0.025mg
EUR 174
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is unconjugated.

Antibody for Hamster HSP110

SPC-195D-A390 0.1mg
EUR 353
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to ATTO 390.

Antibody for Hamster HSP110

SPC-195D-A594 0.1mg
EUR 352
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to ATTO 594.

Antibody for Hamster HSP110

SPC-195D-A655 0.1mg
EUR 352
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to ATTO 655.

Antibody for Hamster HSP110

SPC-195D-A680 0.1mg
EUR 352
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to ATTO 680.

Antibody for Hamster HSP110

SPC-195D-A700 0.1mg
EUR 352
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to ATTO 700.

Antibody for Hamster HSP110

SPC-195D-APC 0.1mg
EUR 351
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to APC .

Antibody for Hamster HSP110

SPC-195D-DY488 0.1mg
EUR 345
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to Dylight 488.

Antibody for Hamster HSP110

SPC-195D-DY633 0.1mg
EUR 342
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to Dylight 633.

Antibody for Hamster HSP110

SPC-195D-HRP 0.1mg
EUR 340
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to HRP.

Antibody for Hamster HSP110

SPC-195D-PCP 0.1mg
EUR 351
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to PerCP.

Antibody for Hamster HSP110

SPC-195D-STR 0.1mg
EUR 350
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to Streptavidin.

Antibody for Hamster HSP110

SPC-195D 0.1mg
EUR 306
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is unconjugated.

Antibody for Hamster HSP110

SPC-195D-A488 0.1mg
EUR 352
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to ATTO 488.

Antibody for Hamster HSP110

SPC-195D-A565 0.1mg
EUR 352
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to ATTO 565.

Antibody for Hamster HSP110

SPC-195D-A633 0.1mg
EUR 352
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to ATTO 633.

Antibody for Hamster HSP110

SPC-195D-ALP 0.1mg
EUR 346
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to Alkaline Phosphatase.

Antibody for Hamster HSP110

SPC-195D-APCCY7 0.1mg
EUR 423
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to APC/Cy7.

Antibody for Hamster HSP110

SPC-195D-BI 0.1mg
EUR 348
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to Biotin.

Antibody for Hamster HSP110

SPC-195D-DY350 0.1mg
EUR 366
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to Dylight 350.

Antibody for Hamster HSP110

SPC-195D-DY405 0.1mg
EUR 355
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to Dylight 405.

Antibody for Hamster HSP110

SPC-195D-DY594 0.1mg
EUR 347
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to Dylight 594.

Antibody for Hamster HSP110

SPC-195D-FITC 0.1mg
EUR 344
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to FITC.

Antibody for Hamster HSP110

SPC-195D-P594 0.1mg
EUR 359
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to PE/ATTO 594.

Antibody for Hamster HSP110

SPC-195D-RPE 0.1mg
EUR 349
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is conjugated to RPE .

Antibody for Hamster HSP110

SPC-195S 0.012mg
EUR 65
Description: A polyclonal antibody for HSP110 from Human | Mouse | Rat | Bovine | Monkey | Hamster | Sheep | Yeast | Shark | Gummy Shark (Mustelus antarcticus) | School Shark (Galeorhinus galeus) . The antibody is produced in rabbit after immunization with Hamster Synthetic peptide derived from the sequence of hamster HSP110; sequence identical to human and mouse. The Antibody is tested and validated for WB, IHC, ICC/IF assays with the following recommended dilutions: WB (1:1000), IHC (1:100). This HSP110 antibody is unconjugated.

Non-sterile hamster serum

HAS05-0050 50 ml
EUR 257.4

Non-sterile hamster serum

HAS05-0100 100 ml
EUR 327.6
The outcomes of this course of display the present state of observe patterns in gynecologic cytology QA. Monitoring interpretive charges for all Bethesda System classes is probably helpful, and it’s most helpful to watch interpretive charges for cytotechnologists individually and compared to your entire laboratory. Laboratories want to find out what stage of discrepancy between cytotechnologist and pathologist interpretations of Pap checks is necessary to trace.
Laboratories ought to think about formalizing procedures and insurance policies to adjudicate such discrepant interpretations. Turnaround time must be monitored in gynecologic cytology, however particular person laboratories ought to decide how one can measure and use turnaround time internally.

Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5.

Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5.
The affiliation of sure sorts of human papillomavirus with cervical carcinoma is effectively established. Human papillomavirus testing is now routinely used to display screen for cervical carcinoma and precursor lesions of the cervix (cotesting and reflex testing) and these outcomes are thought of in affected person triage and administration. To present details about present laboratory practices in human papillomavirus testing and consensus greatest follow statements primarily based on outcomes from the College of American Pathologists’ laboratory-based survey funded by the Centers for Disease Control and Prevention.
The College of American Pathologists submitted a paper-based survey to 1245 laboratories in the United States. After overview of the preliminary outcomes, follow-up Web-based survey outcomes, and a literature overview by an skilled working group, consensus greatest follow statements have been constructed by working group members for presentation at a nationwide consensus convention.
These greatest follow statements have been mentioned and then voted upon by convention members. A complete of 525 laboratories responded to survey questions on human papillomavirus ordering and monitoring practices, whereas 546 responded to the total survey. In most laboratories (87.6%), the high-risk human papillomavirus check is ordered as a reflex check by suppliers. A minority of laboratories (11.9%) routinely bundle low- and high-risk human papillomavirus exams.
Most laboratories (84.4%) don’t restrict testing in sufferers with atypical squamous cells to ladies older than 20 years. More than half of laboratories (53.3%) monitor human papillomavirus optimistic charges in Papanicolaou exams with atypical squamous cells of undetermined significance. It is just not applicable for laboratories to supply low-risk human papillomavirus testing for any scientific circumstance in gynecologic cytology. Laboratories shouldn’t order human papillomavirus testing to resolve diagnostic discrepancies.

College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference on good laboratory practices in gynecologic cytology: background, rationale, and group.

Gynecologic cytopathology is a closely regulated discipline, with Clinical Laboratory Improvement Amendments of 1988 mandating the assortment of many high quality metrics. There is a scarcity of consensus relating to strategies to gather, monitor, and benchmark these information and how these information must be used in a top quality assurance program. Furthermore, the introduction of human papilloma virus testing and proficiency testing has supplied extra information to observe.
To decide good laboratory practices in high quality assurance of gynecologic cytopathology. Data have been collected by way of a written survey consisting of 98 questions submitted to 1245 Clinical Laboratory Improvement Amendments-licensed or Department of Defense laboratories. There have been 541 usable responses. Additional enter was sought by way of a Web posting of outcomes and questions on the College of American Pathologists Web web site.
Four senior authors who authored the survey and 28 cytopathologists and cytotechnologists have been assigned to five working teams to investigate information and current statements on good laboratory practices in gynecologic cytopathology at the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference. Ninety-eight attendees at the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference mentioned and voted on good laboratory follow statements to acquire consensus.
This paper describes the rationale, background, course of, and strengths and limitations of a collection of papers that summarize good laboratory follow statements in high quality assurance in gynecologic cytopathology. It is a priceless broad measure of laboratory high quality to observe the human papillomavirus-positive charges in Papanicolaou exams with atypical squamous cells.
Harnessing the information we’ve gained on the cell cycle disruption attributable to human papillomaviruses (HPV) will seemingly result in improved screening modalities for cervical most cancers and its precursors. An simply utilized biomarker that has excessive specificity and sensitivity would symbolize a gorgeous various or complement to cytology and HPV testing. To date, a quantity of promising markers have been investigated. These embrace p16(INK4A), MIB-1, BD-ProEx C, and L1.
Newer potentialities contain a spread of gene merchandise related to aberrations of chromosome 3q, similar to telomerase, p63, and PIK3CA, as effectively the mixture of biomarkers similar to p16(INK4A) and MIB-1 in the identical assay. Although none of them has but been integrated into screening algorithms or discovered its approach into routine follow, their efficiency traits stay a spotlight of present investigations. This overview summarizes what we all know and the place we hope to go in translating primary pathobiology into scientific follow.
Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5.

Individual estimated sensitivity and workload for handbook screening of SurePath gynecologic cytology.

Data correlating particular person screening sensitivity in gynecologic cytology and workload is restricted. We in contrast the estimated sensitivity of handbook screening of SurePath slides with particular person workload. Estimated sensitivity decided by fast prescreening was correlated with whole workload in a laboratory performing handbook screening of SurePath preparations for a 1 12 months interval. There have been 12 CTs with a complete day by day workload ranging from 8-35 slides.

The imply estimated sensitivity for SurePath was 97.0% (vary 91-100%). The imply estimated sensitivity for the lowest half workload (8-23 slides/day) was considerably greater than that for the highest half workload (23-35 slides/day) (98.Three versus 95.7%, P ≤ 0.001). The highest workload that achieved 100% estimated sensitivity was 30 slides/day. For handbook screening of SurePath slides, particular person estimated sensitivity is correlated with workload even at comparatively low day by day workloads.

Lung Cancer Exosome RNA

P241-LG - Ask for price

Total RNA Isolation Kit II

FATRS--001 100 preps
EUR 308

Total RNA Isolation Kit II

FATRS--050 50 preps
EUR 216

Total RNA Isolation Kit (Tissue)

P-9102 50 samples
EUR 347.25
Description: reagents widely cited

Total RNA Isolation Kit (Plant)

P-9104 50 samples
EUR 347.25
Description: kits suitable for this type of research

Total RNA ExtractionMini KitAnimal Tissues

FYG301-50P 50 Preps Ask for price

Total RNA ExtractionMini KitAnimal Tissues

FYG302-100P 100 Preps Ask for price

Total RNA ExtractionMini KitAnimal Tissues

FYG302-300P 300 Preps Ask for price

Total RNA ExtractionMini KitPlant Tissues

FYG303-100P 100 Preps Ask for price

Total RNA ExtractionMini KitPlant Tissues

FYG303-300P 300 Preps Ask for price

Total RNA ExtractionMini KitPlant Tissues

FYG303-50P 50 Preps Ask for price

Green RNA Lysis Kit 50

GREENE1-RNA 50pack
EUR 180
Description: Bead lysis kits for the homogenization of small, tough samples. Pack of 50, 1.5mL Eppendorf Safe-Lock tubes prefilled with beads. RNase free.

Green RNA Lysis Kit 250

GREENE5-RNA 250pack
EUR 571
Description: Bead lysis kits for the homogenization of small, tough samples. Pack of 250, 1.5mL Eppendorf Safe-Lock tubes prefilled with beads. RNase free.

Pink RNA Lysis Kit 50

PINKE1-RNA 50pack
EUR 178
Description: Bead lysis kits for the homogenization of small, soft or medium-tough samples. Pack of 50, 1.5mL Eppendorf Safe-Lock tubes prefilled with stabilized ceramic beads. RNase free.

Pink RNA Lysis Kit 250

PINKE5-RNA 250pack
EUR 561
Description: Bead lysis kits for the homogenization of small, soft or medium-tough samples. Pack of 250, 1.5mL Eppendorf Safe-Lock tubes prefilled with stabilized ceramic beads. RNase free.

Navy RNA Lysis Kit 50

NAVYE1-RNA 50pack
EUR 198
Description: Bead lysis kits for the homogenization of large, tough samples. Pack of 50, 1.5mL Eppendorf Safe-Lock tubes prefilled with stainless steel beads. RNase free.

Navy RNA Lysis Kit 250

NAVYE5-RNA 250pack
EUR 651
Description: Bead lysis kits for the homogenization of large, tough samples. Pack of 250, 1.5mL Eppendorf Safe-Lock tubes prefilled with stainless steel beads. RNase free.

Red RNA Lysis Kit 50

REDE1-RNA 50pack
EUR 192
Description: Bead lysis kits for the homogenization of large, soft or medium-tough samples. Pack of 50, 1.5mL Eppendorf Safe-Lock tubes prefilled with stabilized ceramic beads. RNase free.

Red RNA Lysis Kit 250

REDE5-RNA 250pack
EUR 622
Description: Bead lysis kits for the homogenization of large, soft or medium-tough samples. Pack of 250, 1.5mL Eppendorf Safe-Lock tubes prefilled with stabilized ceramic beads. RNase free.

YELLOW RNA Lysis Kit 50

YELLOWE1-RNA 50pack
EUR 192
Description: Bead lysis kits for the homogenization of small cell suspensions (ex - E. coli). Pack of 50, 1.5mL Eppendorf Safe-Lock tubes prefilled with stabilized ceramic beads. RNase free.

YELLOW RNA Lysis Kit 250

YELLOWE5-RNA 250pack
EUR 624
Description: Bead lysis kits for the homogenization of small cell suspensions (ex - E. coli). Pack of 250, 1.5mL Eppendorf Safe-Lock tubes prefilled with stabilized ceramic beads. RNase free.

Human Total PSA (t-PSA) ELISA Kit

PRB-5049-TOTAL-5 5 x 96 assays
EUR 2283

5E GREEN RNA Lysis Kit 100

GREEN5E100-RNA 100pack
EUR 386
Description: Bead lysis kits for the homogenization of small, tough samples. Pack of 1000, 5mL Eppendorf Safe-Lock tubes prefilled with beads. RNase free.

5E GREEN RNA Lysis Kit 20

GREEN5E20-RNA 20pack
EUR 138
Description: Bead lysis kits for the homogenization of small, tough samples. Pack of 20, 5mL Eppendorf Safe-Lock tubes prefilled with beads. RNase free.

Green RINO RNA Lysis Kit 50

GREENR1-RNA 50pack
EUR 184
Description: Bead lysis kits for the homogenization of small, tough samples. Pack of 50, 1.5mL RINO screw-cap tubes prefilled with beads. RNase free.

Green RINO RNA Lysis Kit 250

GREENR5-RNA 250pack
EUR 587
Description: Bead lysis kits for the homogenization of small, tough samples. Pack of 250, 1.5mL RINO screw-cap tubes prefilled with beads. RNase free.

5E PINK RNA Lysis Kit 100

PINK5E100-RNA 100pack
EUR 380
Description: Bead lysis kits for the homogenization of small, soft or medium-tough samples. Pack of 100, 5mL Eppendorf Safe-Lock tubes prefilled with stabilized ceramic beads. RNase free.

5E PINK RNA Lysis Kit 20

PINK5E20-RNA 20pack
EUR 136
Description: Bead lysis kits for the homogenization of small, soft or medium-tough samples. Pack of 20, 5mL Eppendorf Safe-Lock tubes prefilled with stabilized ceramic beads. RNase free.

Pink RINO RNA Lysis Kit 50

PINKR1-RNA 50pack
EUR